Insider Trades44 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Sell | TARS | Bobak R. Azamian | President/CEO and Board Chair | 10,000 | $61.55 | $3.5B | -13.35% | +64.54% | $615.5K | -0.58% | 10b5-1 | Sell Now |
| Jun 16, 2026 | Sell | TARS | Jeffrey S Farrow | — | 14,396 | $60.95 | $3.5B | -13.35% | +64.54% | $877.4K | -14.53% | — | Sell Now |
| Mar 20, 2026 | Sell | TARS | Seshadri Neervannan | Chief Operating Officer | 2,989 | $66.75 | $3.5B | -13.35% | +64.54% | $199.5K | -3.48% | 10b5-1 | Sell Now |
| Mar 17, 2026 | Sell | TARS | Elizabeth Yeu Lin | Chief Medical Officer | 1,144 | $68.36 | $3.5B | -13.35% | +64.54% | $78.2K | -1.58% | — | Sell Now |
| Mar 17, 2026 | Sell | TARS | Jeffrey S Farrow | — | 6,430 | $68.36 | $3.5B | -13.35% | +64.54% | $439.6K | -4.50% | — | Sell Now |
| Mar 17, 2026 | Sell | TARS | Seshadri Neervannan | Chief Operating Officer | 11,324 | $68.21 | $3.5B | -13.35% | +64.54% | $772.4K | -4.02% | — | Sell Now |
| Mar 17, 2026 | Sell | TARS | Dianne C. Whitfield | Chief Human Resources Officer | 12,274 | $68.36 | $3.5B | -13.35% | +64.54% | $839.1K | -9.46% | — | Sell Now |
| Mar 17, 2026 | Sell | TARS | Bryan Wahl | General Counsel | 12,440 | $68.36 | $3.5B | -13.35% | +64.54% | $850.4K | -5.74% | — | Sell Now |
| Mar 17, 2026 | Sell | TARS | Aziz Mottiwala | Chief Commercial Officer | 13,056 | $68.36 | $3.5B | -13.35% | +64.54% | $892.5K | -6.20% | — | Sell Now |
| Mar 17, 2026 | Sell | TARS | Bobak R. Azamian | President/CEO and Board Chair | 34,603 | $68.34 | $3.5B | -13.35% | +64.54% | $2.4M | -20.30% | — | Sell Now |
| Mar 4, 2026 | Sell | TARS | Seshadri Neervannan | Chief Operating Officer | 8,366 | $76.67 | $3.5B | -13.35% | +64.54% | $641.4K | -10.57% | 10b5-1 | Sell Now |
| Jan 2, 2026 | Sell | TARS | Dianne C. Whitfield | Chief Human Resources Officer | 15,565 | $80.67 | $3.5B | -13.35% | +64.54% | $1.3M | -12.80% | 10b5-1 | Sell Now |
| Dec 24, 2025 | Sell | TARS | Bobak R. Azamian | President/CEO and Board Chair | 6,000 | $82.51 | $3.5B | -13.35% | +64.54% | $495.1K | -0.35% | 10b5-1 | Sell Now |
| Dec 16, 2025 | Sell | TARS | Seshadri Neervannan | Chief Operating Officer | 1,425 | $78.28 | $3.5B | -13.35% | +64.54% | $111.5K | -0.59% | — | Sell Now |
| Dec 16, 2025 | Sell | TARS | Elizabeth Yeu Lin | Chief Medical Officer | 2,078 | $79.50 | $3.5B | -13.35% | +64.54% | $165.2K | -4.67% | — | Sell Now |
| Dec 16, 2025 | Sell | TARS | Dianne C. Whitfield | Chief Human Resources Officer | 7,397 | $80.10 | $3.5B | -13.35% | +64.54% | $592.5K | -15.96% | 10b5-1 | Sell Now |
| Dec 4, 2025 | Sell | TARS | Bobak R. Azamian | President/CEO and Board Chair | 51,885 | $81.83 | $3.5B | -13.35% | +64.54% | $4.2M | -96.74% | — | Sell Now |
| Sep 24, 2025 | Sell | TARS | Bobak R. Azamian | President/CEO and Board Chair | 6,000 | $55.37 | $3.5B | -13.35% | +64.54% | $332.2K | -0.73% | 10b5-1 | Sell Now |
| Aug 11, 2025 | Sell | TARS | Bobak R. Azamian | President/CEO and Board Chair | 6,000 | $50.00 | $3.5B | -13.35% | +64.54% | $300.0K | -0.73% | 10b5-1 | Sell Now |
| Jun 17, 2025 | Sell | TARS | Jeffrey S Farrow | — | 13,608 | $40.42 | $3.5B | -13.35% | +64.54% | $550.0K | -12.83% | — | Sell Now |
| Jun 16, 2025 | Sell | TARS | Elizabeth Yeu Lin | Chief Medical Officer | 1,006 | $41.08 | $3.5B | -13.35% | +64.54% | $41.3K | -11.56% | — | Sell Now |
| Jun 9, 2025 | Sell | TARS | Aziz Mottiwala | Chief Commercial Officer | 17,500 | $43.76 | $3.5B | -13.35% | +64.54% | $765.8K | -26.90% | 10b5-1 | Sell Now |
| Mar 24, 2025 | Sell | TARS | Bobak R. Azamian | President/CEO and Board Chair | 6,000 | $50.00 | $3.5B | -13.35% | +64.54% | $300.0K | -0.72% | 10b5-1 | Sell Now |
| Mar 18, 2025 | Sell | TARS | Jeffrey S Farrow | — | 3,724 | $47.88 | $3.5B | -13.35% | +64.54% | $178.3K | -4.99% | — | Sell Now |
| Mar 18, 2025 | Sell | TARS | Dianne C. Whitfield | Chief Human Resources Officer | 6,711 | $47.88 | $3.5B | -13.35% | +64.54% | $321.3K | -4.41% | — | Sell Now |
| Mar 18, 2025 | Sell | TARS | Seshadri Neervannan | Chief Operating Officer | 7,583 | $47.89 | $3.5B | -13.35% | +64.54% | $363.1K | -2.98% | — | Sell Now |
| Mar 18, 2025 | Sell | TARS | Bryan Wahl | General Counsel | 9,686 | $47.88 | $3.5B | -13.35% | +64.54% | $463.8K | -5.56% | — | Sell Now |
| Mar 18, 2025 | Sell | TARS | Aziz Mottiwala | Chief Commercial Officer | 10,565 | $47.88 | $3.5B | -13.35% | +64.54% | $505.9K | -4.89% | — | Sell Now |
| Mar 18, 2025 | Sell | TARS | Bobak R. Azamian | President/CEO and Board Chair | 24,216 | $48.03 | $3.5B | -13.35% | +64.54% | $1.2M | -11.49% | — | Sell Now |
| Jun 18, 2024 | Sell | TARS | Jeffrey S Farrow | — | 10,445 | $27.47 | $3.5B | -13.35% | +64.54% | $286.9K | -9.31% | — | Sell Now |
| Mar 18, 2024 | Sell | TARS | Dianne C. Whitfield | Chief Human Resources Officer | 4,314 | $30.60 | $3.5B | -13.35% | +64.54% | $132.0K | -6.24% | — | Sell Now |
| Mar 18, 2024 | Sell | TARS | Bryan Wahl | General Counsel | 4,436 | $30.60 | $3.5B | -13.35% | +64.54% | $135.7K | -5.78% | — | Sell Now |
| Mar 18, 2024 | Sell | TARS | Aziz Mottiwala | Chief Commercial Officer | 4,766 | $30.60 | $3.5B | -13.35% | +64.54% | $145.8K | -5.13% | — | Sell Now |
| Mar 18, 2024 | Sell | TARS | Seshadri Neervannan | Chief Operating Officer | 4,879 | $30.60 | $3.5B | -13.35% | +64.54% | $149.3K | -4.68% | — | Sell Now |
| Mar 18, 2024 | Sell | TARS | Bobak R. Azamian | President/CEO and Board Chair | 10,415 | $30.60 | $3.5B | -13.35% | +64.54% | $318.7K | -9.43% | — | Sell Now |
| Dec 27, 2023 | Sell | TARS | Bobak R. Azamian | President/CEO and Board Chair | 8,000 | $20.22 | $3.5B | -13.35% | +64.54% | $161.8K | -0.95% | 10b5-1 | Sell Now |
| Dec 20, 2023 | Sell | TARS | Jose M. Trevejo | CHIEF MEDICAL OFFICER | 2,252 | $20.00 | $3.5B | -13.35% | +64.54% | $45.0K | -50.01% | 10b5-1 | Sell Now |
| Dec 20, 2023 | Sell | TARS | Bobak R. Azamian | President/CEO and Board Chair | 40,000 | $20.27 | $3.5B | -13.35% | +64.54% | $810.6K | -2.29% | 10b5-1 | Sell Now |
| Nov 30, 2023 | Sell | TARS | Dianne C. Whitfield | Chief Human Resources Officer | 8,355 | $16.31 | $3.5B | -13.35% | +64.54% | $136.3K | -23.78% | — | Sell Now |
| Nov 30, 2023 | Sell | TARS | Bryan Wahl | General Counsel | 8,356 | $16.31 | $3.5B | -13.35% | +64.54% | $136.3K | -20.72% | — | Sell Now |
| Nov 15, 2023 | Sell | TARS | Bobak R. Azamian | President/CEO and Board Chair | 8,000 | $18.37 | $3.5B | -13.35% | +64.54% | $146.9K | -0.30% | 10b5-1 | Sell Now |
| Oct 18, 2023 | Sell | TARS | Bobak R. Azamian | President/CEO and Board Chair | 8,000 | $13.24 | $3.5B | -13.35% | +64.54% | $105.9K | -0.89% | 10b5-1 | Sell Now |
| Oct 5, 2023 | Sell | TARS | Jose M. Trevejo | CHIEF MEDICAL OFFICER | 1,604 | $18.00 | $3.5B | -13.35% | +64.54% | $28.9K | -26.26% | 10b5-1 | Sell Now |
| Sep 20, 2023 | Sell | TARS | Bobak R. Azamian | President/CEO and Board Chair | 8,000 | $17.21 | $3.5B | -13.35% | +64.54% | $137.7K | -0.89% | 10b5-1 | Sell Now |